We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZTA icon
7026
Azenta
AZTA
$1.44B
$953K ﹤0.01%
13,220
-51,760
-80% -$3.87M
DNUT icon
7027
CALL
Krispy Kreme
DNUT
$562M
$953K ﹤0.01%
70,100
-25,100
-26% -$347K
DRIP icon
7028
PUT
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$97.9M
$953K ﹤0.01%
3,855
+2,712
+237% +$562K
EG icon
7029
CALL
Everest Group
EG
$14.1B
$953K ﹤0.01%
3,400
-3,000
-47% -$848K
BMED icon
7030
BlackRock Future Health ETF
BMED
$13.1M
$952K ﹤0.01%
42,914
+27,891
+186% +$644K
PKX icon
7031
POSCO
PKX
$17.2B
$952K ﹤0.01%
21,391
-24,240
-53% -$1.33M
PGJ icon
7032
Invesco Golden Dragon China ETF
PGJ
$93.3M
$951K ﹤0.01%
29,180
-714
-2% -$20.2K
TRN icon
7033
Trinity Industries
TRN
$2.36B
$951K ﹤0.01%
39,285
-32,970
-46% -$890K
VBK icon
7034
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.5B
$951K ﹤0.01%
4,829
-21,325
-82% -$4.62M
BVS icon
7035
Bioventus
BVS
$1.2B
$950K ﹤0.01%
139,165
+77,043
+124% +$786K
TBHC
7036
CALL
DELISTED
The Brand House Collective
TBHC
$950K ﹤0.01%
270,000
+44,100
+20% +$282K
CVEO icon
7037
Civeo
CVEO
$347M
$949K ﹤0.01%
36,696
+24,691
+206% +$664K
RXL icon
7038
ProShares Ultra Health Care
RXL
$91.4M
$948K ﹤0.01%
+21,728
New +$998K
BREZ
7039
CALL
DELISTED
Breeze Holdings Acquisition Corp. Common Stock
BREZ
$948K ﹤0.01%
92,300
-3,700
-4% -$38.1K
AGL icon
7040
CALL
Agilon Health
AGL
$1.6B
$947K ﹤0.01%
1,736
-292
-14% -$148K
BUG icon
7041
Global X Cybersecurity ETF
BUG
$1.5B
$947K ﹤0.01%
37,861
+24,017
+173% +$661K
LTPZ icon
7042
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$772M
$947K ﹤0.01%
14,533
-24,607
-63% -$1.79M
SF
7043
PUT
Stifel
SF
$12.6B
$947K ﹤0.01%
25,350
-50,100
-66% -$2.08M
WPP icon
7044
WPP
WPP
$5.69B
$947K ﹤0.01%
18,716
+11,079
+145% +$650K
AKUS
7045
CALL
DELISTED
Akouos Inc
AKUS
$947K ﹤0.01%
202,000
+27,500
+16% +$97.2K
AGG icon
7046
PUT
iShares Core US Aggregate Bond ETF
AGG
$138B
$946K ﹤0.01%
9,300
-2,000
-18% -$206K
CATC
7047
DELISTED
CAMBRIDGE BANCORP
CATC
$946K ﹤0.01%
11,438
+3,635
+47% +$300K
DRVN icon
7048
CALL
Driven Brands
DRVN
$2.13B
$945K ﹤0.01%
34,300
+2,500
+8% +$68.3K
FMNB icon
7049
Farmers National Banc Corp
FMNB
$949M
$944K ﹤0.01%
62,942
-63,640
-50% -$983K
PEBO icon
7050
Peoples Bancorp
PEBO
$1.47B
$944K ﹤0.01%
35,481
-33,782
-49% -$959K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.